8-K filed May 13, 2025, 7:59 PM ET ticker GTBP CIK 0000109657

leadership confidence high sentiment neutral materiality 0.45

GT Biopharma appoints two new directors; two resign; board reduced to four

GT Biopharma, Inc.

Board increased from 4 to 6 on May 7; Hilary Kramer appointed as non-employee director.
Bruce Wendel resigned from Board and all committees on May 7.
Andrew Ritter appointed as non-employee director on May 8.
Rajesh Shrotriya resigned from Board and all committees on May 12.
Board reduced to 4 members; Kramer chairs Nominating Committee, Ritter chairs Compensation Committee.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Hilary Kramer

Non-Employee Director

GTBP · GT Biopharma, Inc.

Effective: 2025-05-07
Filed: May 13, 2025, 7:59 PM ET

appointed Hilary Kramer as a non-employee director to fill the vacancy created by the increase in the size of the Board

Appointed

Andrew Ritter

Non-Employee Director

GTBP · GT Biopharma, Inc.

Effective: 2025-05-08
Filed: May 13, 2025, 7:59 PM ET

appointed Andrew Ritter as a non-employee director to fill one of the vacancies on the Board.

Departed

Bruce Wendel

Director

GTBP · GT Biopharma, Inc.

Effective: 2025-05-07
Filed: May 13, 2025, 7:59 PM ET

Bruce Wendel resigned as a member of the Board and all committees thereof.

Departed

Rajesh Shrotriya

Director

GTBP · GT Biopharma, Inc.

Effective: 2025-05-12
Filed: May 13, 2025, 7:59 PM ET

Rajesh Shrotriya resigned as a member of the Board and all committees thereof.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Hilary Kramer was appointed as Non-Employee Director at GT Biopharma, Inc..

Action: appointed
Role: Non-Employee Director

Exact text from the filing

appointed Hilary Kramer as a non-employee director to fill the vacancy created by the increase in the size of the Board

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Andrew Ritter was appointed as Non-Employee Director at GT Biopharma, Inc..

Action: appointed
Role: Non-Employee Director

Exact text from the filing

appointed Andrew Ritter as a non-employee director to fill one of the vacancies on the Board.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Bruce Wendel resigned as Director at GT Biopharma, Inc..

Action: resigned
Role: Director

Exact text from the filing

Bruce Wendel resigned as a member of the Board and all committees thereof.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Rajesh Shrotriya resigned as Director at GT Biopharma, Inc..

Action: resigned
Role: Director

Exact text from the filing

Rajesh Shrotriya resigned as a member of the Board and all committees thereof.

View on SEC.gov

GT Biopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-009941

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.